Skip to content
Disclosery

RHUMBLINE ADVISERS: DRUG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of RHUMBLINE ADVISERS on DRUG, newest first. How the timeline and the estimate are built.

RHUMBLINE ADVISERS held 8,733 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 8,733 shares
    Change vs previous 13F +971 shares

    <0.01% of the 13F portfolio, value $613,051.

    13F-HR 0001115418-26-000005 filed by RHUMBLINE ADVISERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,762 shares
    Change vs previous 13F +1,826 shares

    <0.01% of the 13F portfolio, value $566,385.

    13F-HR 0001115418-26-000003 filed by RHUMBLINE ADVISERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 5,936 shares
    Change vs previous 13F -640 shares

    <0.01% of the 13F portfolio, value $463,239.

    13F-HR 0001115418-26-000002 filed by RHUMBLINE ADVISERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 6,576 shares
    Change vs previous 13F -36 shares

    <0.01% of the 13F portfolio, value $398,892.

    13F-HR 0001115418-25-000021 filed by RHUMBLINE ADVISERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 6,612 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $172,633.

    13F-HR 0001115418-25-000017 filed by RHUMBLINE ADVISERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).